137 related articles for article (PubMed ID: 38402080)
1. Intradetrusor botox injection and augmentation cystoplasty trends among spina bifida patients at US freestanding children's hospitals.
Vasdev R; Softness K; Cahill D; Panagides J; Logvinenko T; Saunders R; Bauer S; Estrada C; Wang HS
J Pediatr Urol; 2024 Jun; 20(3):482.e1-482.e6. PubMed ID: 38402080
[TBL] [Abstract][Full Text] [Related]
2. Augmentation cystoplasty rates at children's hospitals in the United States: a pediatric health information system database study.
Lendvay TS; Cowan CA; Mitchell MM; Joyner BD; Grady RW
J Urol; 2006 Oct; 176(4 Pt 2):1716-20. PubMed ID: 16945630
[TBL] [Abstract][Full Text] [Related]
3. Understanding factors influencing primary treatment with intradetrusor onabotulinumtoxinA versus augmentation cystoplasty in patients with spina bifida.
Li B; Peard LM; Zhao S; Graham MK; Adams C; Taylor AS; Thomas JC; Pope JC; Adams MC; Brock JW; Clayton DB
Neurourol Urodyn; 2023 Aug; 42(6):1431-1436. PubMed ID: 37249147
[TBL] [Abstract][Full Text] [Related]
4. Intradetrusor Injections of Botulinum Toxin Type A in Children With Spina Bifida: A Multicenter Study.
Hascoet J; Peyronnet B; Forin V; Baron M; Capon G; Prudhomme T; Allenet C; Tournier S; Maurin C; Cornu JN; Bouali O; Peycelon M; Arnaud A; Renaux-Petel M; Liard A; Karsenty G; Manunta A; Game X
Urology; 2018 Jun; 116():161-167. PubMed ID: 29522865
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Discontinuation of Botulinum Toxin A Intradetrusor Injections for Neurogenic Detrusor Overactivity: A Multicenter Study.
Baron M; Peyronnet B; Aublé A; Hascoet J; Castel-Lacanal E; Miget G; Le Doze S; Prudhomme T; Manunta A; Cornu JN; Gamé X
J Urol; 2019 Apr; 201(4):769-776. PubMed ID: 30359679
[TBL] [Abstract][Full Text] [Related]
6. Five-year cost analysis of intra-detrusor injection of botulinum toxin type A and augmentation cystoplasty for refractory neurogenic detrusor overactivity.
Padmanabhan P; Scarpero HM; Milam DF; Dmochowski RR; Penson DF
World J Urol; 2011 Feb; 29(1):51-7. PubMed ID: 21110030
[TBL] [Abstract][Full Text] [Related]
7. Autologous cell seeded biodegradable scaffold for augmentation cystoplasty: phase II study in children and adolescents with spina bifida.
Joseph DB; Borer JG; De Filippo RE; Hodges SJ; McLorie GA
J Urol; 2014 May; 191(5):1389-95. PubMed ID: 24184366
[TBL] [Abstract][Full Text] [Related]
8. Bladder augmentation versus urinary diversion in patients with spina bifida in the United States.
Wiener JS; Antonelli J; Shea AM; Curtis LH; Schulman KA; Krupski TL; Scales CD
J Urol; 2011 Jul; 186(1):161-5. PubMed ID: 21575969
[TBL] [Abstract][Full Text] [Related]
9. Long-term functional outcomes of augmentation cystoplasty in adult spina bifida patients: A single-center experience in a multidisciplinary team.
Perrouin-Verbe MA; Léon P; Denys P; Mongiat-Artus P; Chartier-Kastler E; Phé V
Neurourol Urodyn; 2019 Jan; 38(1):330-337. PubMed ID: 30350892
[TBL] [Abstract][Full Text] [Related]
10. National trends in augmentation cystoplasty in the 2000s and factors associated with patient outcomes.
Schlomer BJ; Saperston K; Baskin L
J Urol; 2013 Oct; 190(4):1352-7. PubMed ID: 23643599
[TBL] [Abstract][Full Text] [Related]
11. Satisfaction with Detrusor OnabotulinumtoxinA Injections and Conversion to Other Bladder Management in Patients with Chronic Spinal Cord Injury.
Chen SF; Jiang YH; Jhang JF; Kuo HC
Toxins (Basel); 2022 Jan; 14(1):. PubMed ID: 35051012
[TBL] [Abstract][Full Text] [Related]
12. Cost comparison of intra-detrusor injection of botulinum toxin versus augmentation cystoplasty for refractory neurogenic detrusor overactivity in children.
Kim SJ; Nang QG; RoyChoudhury A; Kern AJM; Sheth K; Jacobs M; Poppas DP; Akhavan A
J Pediatr Urol; 2022 Jun; 18(3):314-319. PubMed ID: 35216926
[TBL] [Abstract][Full Text] [Related]
13. Botulinum-a toxin detrusor injection as a novel approach in the treatment of bladder spasticity in children with neurogenic bladder.
Schulte-Baukloh H; Michael T; Stürzebecher B; Knispel HH
Eur Urol; 2003 Jul; 44(1):139-43. PubMed ID: 12814690
[TBL] [Abstract][Full Text] [Related]
14. Switch to Abobotulinum toxin A may be useful in the treatment of neurogenic detrusor overactivity when intradetrusor injections of Onabotulinum toxin A failed.
Bottet F; Peyronnet B; Boissier R; Reiss B; Previnaire JG; Manunta A; Kerdraon J; Ruffion A; Lenormand L; Perrouin Verbe B; Gaillet S; Gamé X; Karsenty G;
Neurourol Urodyn; 2018 Jan; 37(1):291-297. PubMed ID: 28431196
[TBL] [Abstract][Full Text] [Related]
15. Update on Urological Management of Spina Bifida from Prenatal Diagnosis to Adulthood.
Snow-Lisy DC; Yerkes EB; Cheng EY
J Urol; 2015 Aug; 194(2):288-96. PubMed ID: 25839383
[TBL] [Abstract][Full Text] [Related]
16. More Than 15 Years of Experience with Intradetrusor OnabotulinumtoxinA Injections for Treating Refractory Neurogenic Detrusor Overactivity: Lessons to Be Learned.
Leitner L; Guggenbühl-Roy S; Knüpfer SC; Walter M; Schneider MP; Tornic J; Sammer U; Mehnert U; Kessler TM
Eur Urol; 2016 Sep; 70(3):522-8. PubMed ID: 27106070
[TBL] [Abstract][Full Text] [Related]
17. Cost comparison of intra-detrusor injection of botulinum toxin versus augmentation cystoplasty for refractory neurogenic detrusor overactivity in children.
Kim SJ; Nang Q; RoyChoudhury A; Kern A; Sheth K; Jacobs M; Poppas D; Akhavan A
J Pediatr Urol; 2022 Jun; 18(3):321-322. PubMed ID: 35305930
[No Abstract] [Full Text] [Related]
18. Comment on: "Cost comparison of intra-detrusor injection of botulinum toxin versus augmentation cystoplasty for refractory Neurogenic Detrusor Overactivity in Children".
Olsen LH; Djurhuus JC
J Pediatr Urol; 2022 Jun; 18(3):323-324. PubMed ID: 35370093
[No Abstract] [Full Text] [Related]
19. Botulinum toxin A (Botox) intradetrusor injections in adults with neurogenic detrusor overactivity/neurogenic overactive bladder: a systematic literature review.
Karsenty G; Denys P; Amarenco G; De Seze M; Gamé X; Haab F; Kerdraon J; Perrouin-Verbe B; Ruffion A; Saussine C; Soler JM; Schurch B; Chartier-Kastler E
Eur Urol; 2008 Feb; 53(2):275-87. PubMed ID: 17988791
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of intra-detrusor injections of botulinum toxin in patients with spina bifida: A systematic review.
Hascoet J; Manunta A; Brochard C; Arnaud A; Damphousse M; Menard H; Kerdraon J; Journel H; Bonan I; Odent S; Fremond B; Siproudhis L; Gamé X; Peyronnet B;
Neurourol Urodyn; 2017 Mar; 36(3):557-564. PubMed ID: 27187872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
